Company Introduction
Hengyu Biopharmaceutical (Shandong) Co., Ltd.
Business Scope: Food,Skin Care
Main Products: HYPDRN Salmon Collagen Peptide
Registered Capital:RMB 10000000.00
Country/Region:Yantai,China
Hengyu Biopharmaceutical (Shandong) Co., Ltd., which has been established into a comprehensive enterprise that integrates the R&D, production, application and sales of marine biological nucleic acid drug raw materials, medical devices and medical beauty products, is a leading biotechnology company in the industry in China that focuses on the application research and development of marine biological raw materials.
Construction of PDRN application platform: MIGO aesthetic medicine institution which has been operated for nearly ten years; The first Sino-Korean joint venture medical institution in Shandong Free Trade Zone - Korean Medical Beauty, operating based on the international standard, is committed to the promotion, application and nationwide layout of PDRN/PN light aesthetic medicine, and its own brand medical product, aesthetic medicine, cosmetics, food and other efficacy products.
Hengyu Biopharmaceutical (Shandong) Co., Ltd.
Hengyu Biopharmaceutical (Shandong) Co., Ltd., which has been established into a comprehensive enterprise that integrates the R&D, production, application and sales of marine biological nucleic acid drug raw materials, medical devices and medical beauty products, is a leading biotechnology company in the industry in China that focuses on the application research and development of marine biological raw materials.
Construction of PDRN application platform: MIGO aesthetic medicine institution which has been operated for nearly ten years; The first Sino-Korean joint venture medical institution in Shandong Free Trade Zone - Korean Medical Beauty, operating based on the international standard, is committed to the promotion, application and nationwide layout of PDRN/PN light aesthetic medicine, and its own brand medical product, aesthetic medicine, cosmetics, food and other efficacy products.